James Knibbs, who brings a wide breadth of experience in sales leadership, is the new vice president of UK, Ireland, and Australia at Dublin, Ireland-based Mainstay Medical Holdings.
Knibbs, who is steeped in sales leadership of the implantable device realm, was a territory sales manager at Stryker Instruments, then held several roles at Nevro. At Nevro, he was business development manager for North UK to UK Country Manager, and then served as senior area director for Western Europe.
Mainstay Medical is growing significantly and OTW asked Mainstay CEO Jason Hannon about his companies recent decision to expand staff and operations: “We continue to demonstrate the clinical value ReActiv8 brings to patients and are preparing to expand the availability of this compelling therapy in multiple countries.”
“Each of these individuals brings incredible leadership and experience to help build our commercial capabilities, expand in our existing markets, and launch in the U.S. Each of them is experienced in bringing disruptive new technologies to the market and will help us deliver ReActiv8 to patients suffering from mechanical chronic low back pain and the physicians treating this condition. Collectively they complement the existing strong leadership we already have and will leverage the deep history of clinical and scientific leadership we’ve developed.”
James Knibbs told OTW, “I am thrilled to continue to expand access to ReActiv8 for patients in Australia, the UK and Ireland. Launching a novel therapy is a rare opportunity, which affords us the ability to focus on building stellar teams and partnering with physicians to select and care for the right patients.”
“James is a demonstrated market builder. He has the unique opportunity to work with our physician partners in the UK and Australia who are the most experienced ReActiv8 implanters in the world,” stated Jason Hannon to OTW.
